facebook icon twitter icon rss icon
Text: Follow Us
Text: Working to win quality, affordable health care for all Marylanders

Posts from — April 2018

Four Public Hearings Announced for State Reinsurance Proposal

April 20, 2018

Maryland Health Connection sent this bulletin at 04/20/2018 11:58 AM EDT MEDIA RELEASE BALTIMORE (APRIL 20, 2018) – The Maryland Health Benefit Exchange (MHBE), in conjunction with the Maryland Insurance Administration (MIA), will hold a series of hearings to receive public comment to shape Maryland’s application to the federal government for a reinsurance program. The […]... Read more »

Fourth Circuit appeals court strikes down Maryland’s drug price-gouging law

April 19, 2018

The Washington Post Ovetta Wiggins April 13, 2o18 A federal appeals court has struck down a Maryland drug-price-gouging law, a first-of-its-kind measure aimed at lowering the price of off-patent or generic drugs. The U.S. Court of Appeals for the Fourth Circuit said in a 2-to-1 ruling that the 2017 law is unconstitutional because it violates […]... Read more »

4th Circuit strikes down Md.’s generic drug price-gouging law

The Daily Record Steve Lash April 13, 2018 A divided federal appeals court Friday struck down a Maryland law designed to prevent unwarranted price increases by the generic-drug industry, saying the statute unconstitutionally encroaches on Congress’ province to regulate interstate commerce. In its published 2-1 decision, the 4th U.S. Circuit Court of Appeals said the 2017 law […]... Read more »

A Maryland law to prevent ‘unconscionable’ price hikes on old drugs has been struck down

The Washington Post Carolyn Y. Johnson April 13, 2o18 A Maryland law crafted to deter companies from instituting large price increases on old, off-patent drugs was struck down by a federal appeals court Friday, in a decision that could give pause to other states considering similar legislation. The Maryland law, which went into effect in October, was seen as […]... Read more »

Maryland law against price-gouging by drug companies is unconstitutional, appeals court rules

The Baltimore Sun Ian Duncan April 13, 2018 A federal appeals court ruled Friday that a Maryland law passed last year to stop sharp increases in the price of generic medicines is unconstitutional, a setback to new efforts by states to keep down the cost of drugs. In a 2-1 ruling, the 4th Circuit Court […]... Read more »

For Immediate Release

April 13, 2018

Health Advocates Call on Gubernatorial Candidates to Endorse Health Insurance Down Payment Plan to Protect Health Care Access in Maryland... Read more »

Maryland’s year of health care

April 10, 2018

Health care advocates sought to follow up on last year’s anti-price gouging bill for generic prescription drugs with one that would regulate prices for name-brand drugs...Given the outsized role drugs play in health care costs, we urge the Senate to make it a priority.... Read more »

Experts say Md.’s new reinsurance initiative a short-term fix

April 5, 2018

“One important question for the legislature to grapple with is, if we in Maryland have a certain amount of money to invest, what’s the smartest way to invest that money?” said Stan Dorn, a senior fellow at health advocacy group Families USA.... Read more »